Maze Therapeutics, Inc. Common Stock MAZE Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|
| Liquidity | |||
| Current ratio | 17.9×— | 15.5×— | |
| Leverage | |||
| Debt-to-equity | 0.2×— | 0.1×— | |
| Per Share | |||
| Book value per share | $6.34— | $8.26— | |
| Valuation | |||
| Market capitalization | $1.48B+201% | —— | |
| Price / book | 4.3×— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Maze Therapeutics, Inc. Common Stock's ratios come from?
- Every ratio is computed from Maze Therapeutics, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
